Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status

Shahzaad Khadeem Jahangier; Rubina Qamar; Aurora Internal Medicine Residents; Aurora Complex General Surgical Oncology Faculty

doi:10.1200/JCO.2024.42.16_suppl.12021

Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status

Shahzaad Khadeem Jahangier, Rubina Qamar, Aurora Internal Medicine Residents, Aurora Complex General Surgical Oncology Faculty

Advocate Health - Midwest

Research output: Contribution to journal › Meeting abstract

Original language	American English
Pages (from-to)	12021-12021
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	42
Issue number	16_suppl
DOIs	https://doi.org/10.1200/JCO.2024.42.16_suppl.12021
Status	Published - Jun 1 2024

Keywords

Breast cancer therapy
cardiac dysfunction

Access to Document

10.1200/JCO.2024.42.16_suppl.12021License: Unspecified

https://libkey.io/libraries/1712/10.1200/JCO.2024.42.16_suppl.12021

Cite this

Jahangier, S. K., Qamar, R., Internal Medicine Residents, A., & Complex General Surgical Oncology Faculty, A. (2024). Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status. Journal of Clinical Oncology, 42(16_suppl), 12021-12021. https://doi.org/10.1200/JCO.2024.42.16_suppl.12021

Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status. / Jahangier, Shahzaad Khadeem; Qamar, Rubina; Internal Medicine Residents, Aurora et al.
In: Journal of Clinical Oncology, Vol. 42, No. 16_suppl, 01.06.2024, p. 12021-12021.

Research output: Contribution to journal › Meeting abstract

Jahangier, SK, Qamar, R, Internal Medicine Residents, A & Complex General Surgical Oncology Faculty, A 2024, 'Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status', Journal of Clinical Oncology, vol. 42, no. 16_suppl, pp. 12021-12021. https://doi.org/10.1200/JCO.2024.42.16_suppl.12021

@article{317ea83002984e7c9ac7bf512018c5b1,

title = "Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status",

keywords = "Breast cancer therapy, cardiac dysfunction",

author = "Jahangier, {Shahzaad Khadeem} and Rubina Qamar and {Internal Medicine Residents}, Aurora and {Complex General Surgical Oncology Faculty}, Aurora",

note = "Jahangier SK, Qamar R. Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status. Journal of Clinical Oncology. 2024/06/01 2024;42(16_suppl):12021-12021. doi:10.1200/JCO.2024.42.16_suppl.12021",

year = "2024",

month = jun,

day = "1",

doi = "10.1200/JCO.2024.42.16_suppl.12021",

language = "American English",

volume = "42",

pages = "12021--12021",

journal = "Journal of Clinical Oncology",

number = "16_suppl",

}

TY - JOUR

T1 - Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status

AU - Jahangier, Shahzaad Khadeem

AU - Qamar, Rubina

AU - Internal Medicine Residents, Aurora

AU - Complex General Surgical Oncology Faculty, Aurora

N1 - Jahangier SK, Qamar R. Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status. Journal of Clinical Oncology. 2024/06/01 2024;42(16_suppl):12021-12021. doi:10.1200/JCO.2024.42.16_suppl.12021

PY - 2024/6/1

Y1 - 2024/6/1

KW - Breast cancer therapy

KW - cardiac dysfunction

UR - https://institutionalrepository.aah.org/auroragme/507

UR - https://libkey.io/libraries/1712/10.1200/JCO.2024.42.16_suppl.12021

U2 - 10.1200/JCO.2024.42.16_suppl.12021

DO - 10.1200/JCO.2024.42.16_suppl.12021

M3 - Meeting abstract

VL - 42

SP - 12021

EP - 12021

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16_suppl

ER -

Predictors of cardiotoxicity in patients with early breast cancer treated with doxorubicin and/or trastuzumab: Implications of race/ethnicity and insurance status

Keywords

Access to Document

Other files and links

Cite this